Vitamin C Deficiency-Induced Pulmonary Arterial Hypertension.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32033656.
- Also identified by DOI 10.1016/j.chest.2019.06.043.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of a man in his 60s who developed pulmonary arterial hypertension (PAH) in association with profound vitamin C deficiency. Decreased availability of endothelial nitric oxide and activation of the hypoxia-inducible family of transcription factors, both consequences of vitamin C deficiency, are believed to be mechanisms contributing to the pathogenesis of the pulmonary hypertension. The PAH resolved following vitamin C supplementation. The current case highlights the importance of testing for vitamin C deficiency in patients with PAH in the proper clinical setting.
Medical subject headings
- Ascorbic Acid Deficiency
- Pulmonary Arterial Hypertension